drugset / Trial / NCT03020563

Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures?

NCT03020563 ↗

Phase 4 Withdrawn University of Minnesota
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine whether liposomal bupivacaine wound infiltration decreases pain scores and narcotic use when compared to bupivacaine alone after open reduction internal fixation of midshaft clavicle fractures.

Timeline

Start
2017-08-23
Primary completion
2018-01-01
Completion
2018-01-01

Outcome

Outcome not reported

Stopped: “no longer necessary”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified — Other
Comparator Bupivacaine Other / unclassified — —

Indications

No indication recorded.